Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · IEX Real-Time Price · USD
36.35
+1.78 (5.15%)
At close: Mar 28, 2024, 4:00 PM
36.32
-0.03 (-0.08%)
After-hours: Mar 28, 2024, 4:35 PM EDT

Tarsus Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Net Income
-135.89-62.09-13.83-26.81-4.67-1.32
Depreciation & Amortization
1.420.790.610.250.070
Share-Based Compensation
19.8313.468.460.840.020.01
Other Operating Activities
-2.85-1.198.514.590.910.13
Operating Cash Flow
-117.49-49.033.75-21.14-3.67-1.18
Capital Expenditures
-5.5-0.51-0.59-0.46-0.18-0.01
Change in Investments
146.11-144.120000
Investing Cash Flow
140.6-144.63-0.59-0.46-0.18-0.01
Share Issuance / Repurchase
120.1874.940.3292.0400
Debt Issued / Paid
1019.13001.990
Other Financing Activities
--0.08-0.339.7357.463.56
Financing Cash Flow
130.1893.990.02131.7759.453.56
Net Cash Flow
153.29-99.673.18110.1855.62.37
Free Cash Flow
-123-49.543.16-21.59-3.85-1.19
Free Cash Flow Margin
-704.96%-191.88%5.54%---
Free Cash Flow Per Share
-4.19-2.010.15-3.48-1.63-0.68
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).